Vascular Therapies Announces Presentation of Phase 3 Clinica

/PRNewswire/ -- Vascular Therapies, a privately held biotechnology company is developing Sirogen™, a proprietary sirolimus formulation for intraoperative local...

Related Keywords

New York , United States , Lenox Hill Hospital , American , Sriram Iyer , John Mcdermott , Maria Devita , American Association Of Nephrology Annual Meeting , Vascular Therapies Inc , Company Contact , Vascular Therapies , Late Breaking Clinical Trials , American Association , Nephrology Annual , Senior Nephrologist , Medical Monitor , Chief Scientific Officer , Chief Executive Officer , Chronic Kidney Disease , Fast Track , Orphan Drug , Nc , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,